N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide

C11H13N3O2S2 — CID 154869141

IUPACN-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide
SMILESO=S(=O)(NC1CCC2CC21)c1cnc2sccn12
InChIInChI=1S/C11H13N3O2S2/c15-18(16,13-9-2-1-7-5-8(7)9)10-6-12-11-14(10)3-4-17-11/h3-4,6-9,13H,1-2,5H2
InChIKeyFNGCUZMOVOXDAK-UHFFFAOYSA-N
MW283.38 g/mol
LogP1.47
Rot. Bonds3

About N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide

N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide (PubChem CID 154869141) has the molecular formula C11H13N3O2S2 and a molecular weight of 283.38 g/mol. Its IUPAC name is N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide.

Molecular Properties

Compound NameN-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide
PubChem CID154869141
Molecular FormulaC11H13N3O2S2
Molecular Weight283.38 g/mol
Exact Mass283.04
IUPAC NameN-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide
SMILESO=S(=O)(NC1CCC2CC21)c1cnc2sccn12
InChIInChI=1S/C11H13N3O2S2/c15-18(16,13-9-2-1-7-5-8(7)9)10-6-12-11-14(10)3-4-17-11/h3-4,6-9,13H,1-2,5H2
InChIKeyFNGCUZMOVOXDAK-UHFFFAOYSA-N
XLogP1.47
TPSA63.47 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms18
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500283.38
LogP ≤ 51.47
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(4-propan-2-yl-1,3-thiazol-2-yl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide
CID 167918868
5-oxo-N-[(1R,2R,6R,7S,8R)-8-tricyclo[5.2.1.02,6]decanyl]-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxamide
CID 124731181
6-hydrazinyl-N-(7-oxabicyclo[2.2.1]heptan-2-yl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide
CID 80714351
2-imidazo[2,1-b][1,3]thiazol-5-ylsulfonyl-3,4-dihydro-1H-isoquinoline-4-carboxylic acid
CID 167853907
6-bromoimidazo[2,1-b][1,3]thiazole-5-sulfonyl chloride
CID 25267672
5-cyclohexylimidazo[2,1-b][1,3]thiazole
CID 67095055
N-cyclobutyl-6-(methylamino)imidazo[2,1-b][1,3]thiazole-5-sulfonamide
CID 62415032
2-bicyclo[2.2.1]heptanyl 5-oxo-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate
CID 138042168
N-[2-chloro-4-(2-cyanopyrrol-1-yl)-1-(4-methylpiperidin-1-yl)-1-oxobutan-2-yl]imidazo[2,1-b][1,3]thiazole-5-sulfonamide
CID 140570531
N-cyclopentyl-7-methyl-5-oxo-[1,3]thiazolo[3,2-a]pyrimidine-6-sulfonamide
CID 23004527
6-amino-N-(4-methylcyclohexyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide
CID 62149971
N-(3-methylcyclopentyl)-5-oxo-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxamide
CID 114549960

Frequently Asked Questions

What is the IUPAC name of N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide?
The IUPAC name of N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide (CID 154869141) is N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide.
What is the SMILES notation for N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide?
The canonical SMILES for N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide is O=S(=O)(NC1CCC2CC21)c1cnc2sccn12.
What is the InChIKey of N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide?
The InChIKey is FNGCUZMOVOXDAK-UHFFFAOYSA-N. The full InChI is InChI=1S/C11H13N3O2S2/c15-18(16,13-9-2-1-7-5-8(7)9)10-6-12-11-14(10)3-4-17-11/h3-4,6-9,13H,1-2,5H2.
What are the key properties of N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide?
N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide has a molecular weight of 283.38 g/mol, XLogP of 1.47, 3 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-bicyclo[3.1.0]hexanyl)imidazo[2,1-b][1,3]thiazole-5-sulfonamide is sourced from PubChem (CID 154869141), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).